KDA Group Inc. announced the formation of its strategic advisory board (the "Strategic Board"), comprised of respected business leaders who will provide guidance and assistance to KDA's management team in its efforts and decision-making to build, strengthen and grow its business model. Inaugural members of KDA's Strategic Board are as follows: Sylvain Duvernay; He has over 20 years of experience in pharmaceutical and international business. Mr. Duvernay filled the position of Vice-President for Strides Arcolab Ltd. a pharmaceutical generic product company involved in softgel, injectable and solid dose manufacturing. He led its Canadian operations as well as its business development in the United States. Jean-Pierre Robert ­ - Mr. Robert is very much involved in the post-COVID-19 preparations for the pharmaceutical and medical equipment sectors. Since 2016, Mr. Robert has held the position of President of Campus des Technologies Médicales (CTS), an accelerator that provides start-up companies with a structured environment to help them achieve market momentum and international exposure.